State Ledger
Company profile

Ovid Therapeutics Inc. CIK 1636651

Ticker
OVID (Nasdaq)
Industry
Pharmaceutical Preparations
Headquarters
New York, NY 10001
Fiscal year end
2025 (FY)
Market Data
Close
$2.40
Change
-$0.06
Change %
-2.44%
Volume
55,159

OVID · trading date Oct 12, 2026 · previous close $2.46 · source: Alpaca (IEX feed, not consolidated full-market data).

Key Financials
Revenue
$7.25M
Net income
-$17.41M
Total assets
$150.93M
Total liabilities
$20.27M
Stockholders' equity
$130.66M
Cash & equivalents
$13.15M
Operating income
-$42.44M
Operating cash flow
-$38.33M
Capital expenditures
$0

Fiscal year 2025, via 10-K filed 2026-03-18. A dash means this figure wasn't reported in the source filing under a field State Ledger recognizes - not that the value is zero.

Financial Performance
Operating margin
-585.2%
Net margin
-240.1%
Free cash flow
-$38.33M
Free cash flow margin
-528.6%
Liabilities / assets
13.4%
Equity / assets
86.6%
CapEx / revenue
0.0%
Operating cash flow / net income
2.20×

Derived from the fiscal year 2025 figures above. These metrics are mathematical calculations and do not represent a rating or assessment of the company.

Financial History
Fiscal yearRevenueNet incomeAssetsLiabilitiesEquity
2025 $7.25M -$17.41M $150.93M $20.27M $130.66M
2024 $566.0K -$26.43M $92.17M $23.94M $68.23M
2023 $392.0K -$52.34M $144.03M $56.23M $87.80M
2022 $1.50M -$54.17M $155.27M $22.99M $132.27M
2021 $208.38M $122.83M $194.54M $14.80M $179.75M
Company Details
SIC code
2834
State of incorporation
DE
Active filer
Yes
Most recent SEC filing
Form 144
2026-08-24
Financials filed via
Form 10-K
filed 2026-03-18

"Most recent SEC filing" may differ from the filing used for the financial figures above.

Location
New York, NY 10001
441 NINTH AVENUE, 14TH FLOOR
Data & Methodology

SEC EDGAR submissions API (identity, collected Sep 19, 2026, 15:11 UTC) and SEC XBRL Company Facts API (financials, collected Sep 26, 2026, 15:44 UTC) · figures as originally filed, not restated · a dash always means a value wasn't reported, never a real zero.

← Back to New York — Public Companies